PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.06
Similar ESG score to EXEL's 62.63. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
57.55
Environmental score 1.1-1.2x EXEL's 53.09. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
60.01
Social score 80-90% of EXEL's 67.03. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
62.62
Governance score 90-95% of EXEL's 67.78. Bill Ackman would demand clear governance improvement catalysts.